Market Research Logo

Kalorama 2017 IVD Market Research Bundle (The Worldwide Market for In Vitro Diagnostic Tests, NGS, Companion, US IVD)

This bundle of previously published Kalorama Information studies allows decision-makers and researchers to review critical information in order to be prepared for events coming in 2017.   This In Vitro Diagnostics Market bundle contains the following reports, covering a range of IVD topics.   

      The World Market for In Vitro Diagnostics, 10thEdition.  Published August 2016
United States In Vitro Diagnostics Markets Published July 2016
Companion Diagnostic Testing Markets Published April 2016
Next Generation Sequencing Markets Published September 2016

These are the full PDFs, as published this year.   In addition, Kalorama Information's White paper Top 5 Trends to Watch in 2017 is provided.  Eachis presented as the original PDF.  Each report has its own table of contents  


K a l o r  a m a    2 0 1 7   I V D   M a r k e t   B u n d l e 


---THE WORLDWIDE MARKET FOR IN VITRO DIAGNOSTICS ---

ONE: EXECUTIVE SUMMARY
Scope and Methodology
Size and Growth of the Market
Market Trends
TWO: INTRODUCTION
Report Design
Lab Medicine Disciplines and Applications
Market Analysis of IVD Market Segments
IVD Companies Mix and Match
Distribution Agreements
Licenses and Collaboration agreements
Test Services
Top Suppliers and Niche Players
IVDs Then and Now – A 20 Year Perspective
In the Beginning to Now
Surprises and Disappointments
Future
Point of View
THREE: OVERVIEW OF GLOBAL IN VITRO DIAGNOSTIC MARKETS
Background
Population and Disease Demographics Worldwide
Emerging Markets as a Market Driver
World Segments of the IVD Market and IVD Market Evolution
Specific Country Information
The United States of America
Japan
Europe: Slow Growth - Effects of Austerity
IVD Directive Update
China
India
Brazil
Russia
Canada
Saudi Arabia
Asia Review
FOUR: TRENDS AND INNOVATION
Background
Personal Genomics – A Work in Progress
Sequencing Enters the Clinic
Digital Technology, IT, BIG Data
Gene Editing
Wearables
Breath Test Advances
FIVE: POINT-OF-CARE TESTS
Overview and Trends
Professional POC
OTC Self Testing
Colon Cancer Screening
Lipid Testing
The Major POC Test Players
Diabetes Testing – Blood Glucose Monitoring
Glucose Testing in Tight Economics
IT to Aid Diabetes Management
Diabetes Market Analysis
Blood Glucose Self-Testing
Noninvasive Testing Devices
Continuous Self Testing en Route to the Artificial Pancreas
Blood Glucose Testing by Professionals
Diabetes Testing – Glycated Hemoglobin
Genes and Other Markers of Diabetes
SIX: THE CORE LAB
Core Lab Overview and Trends
Connectivity
Overview of Chemistry Tests
Lab Automation
Market Analysis
Rapid Response Systems
Critical Care Analysis
User Apps
Urinalysis
The Commercial Outlook for Chemistry Tests
SEVEN: IMMUNOASSAYS
Overview and Trends
Immunoassay Technology Continues to Evolve
Mass Spectrometry
Immunoassays in the Core Lab
Radioimmunoassays
Market Analysis
Leading Suppliers and Growth Potential
Mature Assay Segment
Thyroid Function
Therapeutic Drug Monitoring
Anemia
Toxicology/DAU
Allergy
Maturing Immunoassays
Proteins
Growth Immunoassays
Vitamin D
Tumor Markers
Cardiac Markers
Autoimmune
Rheumatoid Arthritis
Gastrointestinal Disorders
Transplant Management
Women’s Health
Alzheimer’s Disease
Miscellaneous
Point-of-Care OTC and Professional Use
Pregnancy Testing
Cardiovascular Diagnostics
Drugs of Abuse/Therapeutic Drug Monitoring
The Commercial Outlook for Immunoassays
EIGHT: MOLECULAR ASSAYS
Overview
Sample Preparation and Quality Control
Advanced Molecular Tests and Technologies
Exosome Sequencing
Liquid Biopsy
Metabolomic Profiling
Information Technology for Test Value
Forensic Studies – An Emerging Opportunity
Test Platforms
Major Players
Market Analysis
Oncology
Inherited Diseases
Prenatal and Newborn Testing
Tissue Typing
The Commercial Outlook for Molecular Tests
NINE: HEMATOLOGY
Overview of Hematology and Trends
Digital Image Analysis
Digital Evolution
Decentralized Hematology Testing
Hemoglobin/Hematocrit at the POC
Market Analysis: Leading Suppliers
The Commercial Outlook for Hematology Tests
TEN: COAGULATION
Overview and Trends of Coagulation and Immunohematology Tests
Special Topics
Direct Oral Anticoagulants (DOACs)
D-dimer
Market Analysis
Lab-based Testing
Genetic Markers of Hypercoagulopathies
Decentralized Coagulation Testing – Professional Use
Decentralized Coagulation Testing – OTC
Platelet Testing
Leading Suppliers
The Commercial Market for Coagulation Tests
ELEVEN: MICROBIOLOGY AND VIROLOGY
Overview
Special Topics
Some Disease Facts
Pregnancy Infections – Beyond Zika
Emerging Disease Threats
Antimicrobial Drug Resistance
Mass Spectrometry Not a Pipedream
Infection Screening Serology
Microbiome – Bacteria in Disease Processes
Market Analysis
Supplies
Chromogenic Media
Microbial Identification and Antimicrobial Sensitivity Tests
Automated Microbiology
Blood Culture
Rapid Tests
Immunoassays – Lab-based
Immunoassays – Rapid
Molecular Tests
The Commercial Outlook for Microbiology / Virology Tests
TWELVE: BLOOD BANKING SERVICES
Overview and Trends
are all these transfusions good medicine
Artificial blood
Pathogen Alerts
Platelet Safety
Market Analysis
Blood Grouping and Typing
Immunoassays
Nucleic Acid Testing (NAT)
The Commercial Outlook for Blood Banking
THIRTEEN: HISTOLOGY AND CYTOLOGY
Overview
Special Topics
Histology Automation
Advanced Analysis Solutions
HPV Goes Core Lab
Market Analysis
Histology/Cytology
Immunohistochemistry and In Situ Hybridization
Pharmacodiagnostic Histology
Digital Imaging and Computational Pathology
Circulating Tumor Cells
Flow Cytometry
The Commercial Outlook for Histology and Cytology Tests
FOURTEEN: COMPANY PROFILES: THE TOP TIER
Abbott Diagnostics
Recent Revenue History:
2014/2015 Business Highlights
Core Lab
Immunoassays
Hematology
Coagulation
Blood Bank
Point of Care
Diabetes
Molecular
IntelligentMDx Alliance
PLEX-ID
Iridica
Histology
Alere Inc
Recent Revenue History:
Alere in Africa
Product News
Microbiology
Molecular
Arkray
Recent Revenue History:
Urinalysis
Diabetes
Molecular
Beckman Coulter, Inc. / Danaher
Recent Revenue History:
Core Lab
Hematology
Immunoassays
Iris International
Microbiology
Molecular
Sequencing
Genomics
Information Technology
Flow Cytometry
Becton, Dickinson and Company (BD)
Recent Revenue History:
Traditional Microbiology
Blood Culture
Mass Spectrometry
Veritor System - Immunoassays
Histology
HPV
Molecular
The BD MAX Enterprise
Sequencing
Flow Cytometry
bioMérieux Inc
Recent Revenue History:
Traditional Microbiology
Blood Culture
Immunoassays
Rapid Tests
Oncology
Mass Spectrometry
Molecular Strategy
Sequencing Service
Expansion
Bio-Rad Laboratories, Inc
Recent Revenue History
Controls
Diabetes
Blood Bank
Immunoassays
Flow Cytometry
Digital PCR
Danaher Corporation
Recent Revenue History
Hologic, Inc
Recent Revenue History:
The Gen-Probe/PANTHER Business
Blood Bank
Quest Contract
Instrumentation Laboratory (IL)
Recent Revenue History: ($ millions)
Coagulation
Direct Oral Anticoagulant Testing (DOAC)
Coagulation Automation
Critical Care
Ortho Clinical Diagnostics (OCD)
Recent Revenue History:
Blood Bank
QIAGEN N.V
Recent Revenue History
Tuberculosis
Infectious Disease Testing
Transplant Medicine and HAIs
Personalized Healthcare
Companion Diagnostics
Liquid Biopsy/CTC
Instrumentation Base
Rotor-Gene Q – Clinical Diagnostics
Sequencing
Exosomes
Information Technology
Collaborations
Forensics
Radiometer A/S
Recent Revenue History:
Immunoassays
Hemocue AB
Roche Diagnostics
Recent Revenue History
New Enterprises
Global Access Program for HIV
Core Lab
Hematology
Immunoassays
Transplant Medicine
Diabetes
Point of Care
Core Molecular Tests
Virology
STDs
A POC Enterprise – Liat
Prenatal and cfDNA
HPV
Blood Bank
Liquid Biopsy
Personalized Medicine
Sequencing – Putting the Pieces Together
Siemens Healthcare Diagnostics
Recent Revenue History:
Core Lab
Immunoassays
Urinalysis
Critical Care
POC Connectivity
Hematology
Histology
Coagulation
Molecular
Companion Diagnostics
China
Sysmex Corporation
Recent Revenue History:
Hematology
Coagulation
Core Lab
Inostics GmbH
Flow Cytometry
Thermo Fisher Scientific Inc
Recent Revenue History:
Sequencing
Microbiology
Microbiology IT
Transplant
Quality Control
Mass Spectrometry
Point of Care
Molecular
Oncology
Forensic
Werfen Group S.A
FIFTEEN: Company Profiles: The Second Tier
Affymetrix Inc
Recent Revenue History
Axiom Genotyping Applications
Agilent Technologies
Recent Revenue History:
Agilent in Genomics
PCR
Sequencing
Arrays
Cepheid
Recent Revenue History:
Hospital Acquired Infections (HAI)
TB
Infectious Diseases
Virology
Oncology
Eiken Chemical Co., Ltd
Recent Revenue History:
ERBA Mannheim
ERBA Diagnostics, Inc
Recent Revenue History:
Product Expansion
DiaSorin S.p.A
Recent Revenue History:
Immunoassays
Molecular
Fujirebio Diagnostics, Inc
Recent Revenue History:
Molecular
Illumina
Recent Revenue History:
Understand Your Genome Symposium
Sequencing
Sequencing Kits
Sample Prep
IVD Business
Oncology
HLA Typing
Information Technology
CRISPR
Forensics
CLIA Lab Service
Sample to Insight
Making a Market
Expansion in China
LabCorp, Laboratory Corporation of America
Recent Revenue History:
Infectious Diseases
Prenatal
Sequencing
Oncology
Information Technology
Forensic
Expanding Food Testing
Luminex Corporation
Recent Revenue History: $ million
Business Expansion
MAGPIX Multiplexing
Next Generation NxTag
Menarini Diagnostics
Recent Revenue History:
Mindray Medical International Limited
Recent Revenue History:
Core Lab
Hematology
Coagulation
Myriad Genetics
Recent Revenue History: (millions)
Molecular Product News
Beyond Cancer
IP Update
PerkinElmer, Inc. (PE)
Recent Revenue History: ($ million, estimated)
Newborn Testing
Prenatal Testing
Histology
Information Technology
India
China
Quest Diagnostics
Recent Revenue History:
Oncology
Infectious Diseases
Prenatal and Women’s Health
Market Expansion
Insurance and Wellness Business
Quest Partners for Market Accessibility
Information Technology
Quidel Corporation
Recent Revenue History:
Point of Care
Immunoassays
Molecular
Lyra Product Line
Solana Molecular System
AmpliVue Product Line
Savanna (formerly Wildcat)
Randox Laboratories Ltd
Recent Revenue History:
Controls
Immunoassays
Molecular
Prenatal
POC
Royal Philips
Histology
Point of Care
TOSOH Corporation
Recent Revenue History: (
Immunoassays
Transasia Bio-Medicals Ltd
Trinity Biotech plc
Recent Revenue History: $ million
Wako Pure Chemical Industries, Ltd
Recent Revenue History
SIXTEEN: COMPANY PROFILES: BLOOD BANK SPECIALISTS
BloodSource
Cerus Corporation
Recent Revenue History
Grifols
Recent Revenue History:
Clinical Analysis
Blood Transfusion Business
International Programs
Molecular
Haemokinesis Pty Ltd
Immucor, Inc
Recent Revenue History
Transfusion Medicine
Transplant Diagnostics
IMMUCOR DX Laboratory Service
Micro Typing Concepts (MTC)
Quotient Limited
Recent Revenue History
Traditional Blood Grouping
MosaiQ Platform
SEVENTEEN: COMPANY PROFILES: COAGULATION SPECIALISTS
Diagnostica Stago, S.A.S
Recent Revenue History
Instrumentation
Test Kits
Microvisk Technologies
EIGHTEEN: COMPANY PROFILES: CORE LAB AND OTHER COMPANIES
AB SCIEX Pte Ltd
Bruker BioSciences Corporation
Recent Revenue History
Microbiology
Tissue Analysis
EKF Diagnostics Holdings Plc
Recent Revenue History
Lab-based Assays
Molecular
EliTech Group S.A.S
MedTest DX
Microsaic Systems plc
Nova Biomedical
Diabetes
Scienion AG
Sekisui Diagnostics
Shimadzu Scientific Instruments
Tecan Group
Recent Revenue History
NINETEEN: COMPANY PROFILES: CTC & LIQUID BIOPSY TEST PROVIDERS
Angle plc
ApoCell, Inc
Biocept, Inc
Recent Revenue History
Menu Expansion
Reimbursement
Biodesix, Inc
Celsee Diagnostics (formerly DeNovo Sciences, Inc.)
Circulogene Theranostics
Clearbridge BioMedics
Cynvenio Biosystems, Inc
Epic Sciences Inc
Collaborations
Exosome Diagnostics, Inc
Fluxion Biosciences, Inc
Genyo – Centre for Genomics
Janssen Diagnostics, LLC (formerly Veridex, LLC)
Recent Revenue History
Menarini-Silicon Biosystems
Qiagen Hanover
Recent Revenue History
ScreenCell
WaveSense LLC
TWENTY: COMPANY PROFILES: DIABETES SPECIALISTS
Animas Corporation
Recent Revenue History
Ascensia Diabetes Care (formerly Bayer Diabetes Care)
Recent Revenue History
Bigfoot Biomedical
Cellnovo Group
Recent Revenue History
Debiotech SA
DexCom, Inc
Recent Revenue History
Dexcom Product Overview
Collaborations
Diasend AB
Recent Revenue History
Gentag, Inc
Gentag’s Patent Position
Glucosense Diagnostics Ltd
Glysure Limited
Glytec Inc
iHealth Lab Inc
Insulet Corporation
Recent Revenue History
Neighborhood Diabetes Inc
Integrity Applications Inc
LabStyle Innovations Corp
Recent Revenue History
Lifescan Inc
Recent Revenue History
IP Issues
Medtronic Inc
Recent Revenue History
Nemaura Medical, Inc
Nightscout
Nipro Diagnostics, Inc
Recent Revenue History:
Sanofi Diabetes
Recent Revenue History
Tandem Diabetes Care, Inc
Recent Revenue History
TypeZero Technologies
Verily (formerly Google Life Sciences)
TWENTY-ONE: COMPANY PROFILES: HEMATOLOGY (CELL ANALYSIS) SPECIALISTS
CellaVision AB
Recent Revenue History
Horiba Medical
Recent Revenue History
Chemistry
Medica Corporation
Oncascan Limited
West Medica
Zyomyx Inc
TWENTY-TWO: COMPANY PROFILES: HISTOPATHOLOGY SPECIALISTS
Advanced Cell Diagnostics (ACD)
Amoy Diagnostics Co. Ltd
Applied Spectral Imaging Inc. (ASI)
BioGenex Laboratories Inc
BioView Ltd
Recent Revenue History
Circulomics Inc
Dako A/S
Recent Revenue History
Special Stains
Immunohistochemistry (ICH)
Companion Diagnostics
Flow Cytometry
Automation
Alliances
Definiens
EMD Millipore
HTG Molecular Diagnostics
Recent Revenue History
Kapa Biosystems Inc
Leica Biosystems
Collaborations
Omnyx LLC
Ventana Medical Systems Inc
Recent Revenue History
Digital Pathology
Virtuoso Software Update
Product News
Automation
Partnerships
Visiopharm
TWENTY-THREE: COMPANY PROFILES: IMMUNOASSAY SPECIALISTS
BG Medicine, Inc
Recent Revenue History
Binding Site Group Ltd. (The)
Recent Revenue History
Biohit Oyj
Recent Revenue History
Market Expansion
Biomerica Inc
Recent Revenue History
Bio-Techne Corporation
Recent Revenue History
Corgenix Medical Corporation
Critical Diagnostics
Diaxonhit
Recent Revenue History
Euroimmun AG
Recent Revenue History
Hob Biotech
Immunodiagnostic Systems (IDS)
Recent Revenue History
INOVA Diagnostics, Inc
Integrated Diagnostics (Indi)
One Lambda
Recent Revenue History
Orgentec Diagnostika
Recent Revenue History
Protagen Diagnostics
Quanterix Corporation
Response Biomedical Corp
Recent Revenue History
Singulex, Inc
Theradiag
Recent Revenue History
VolitionRx Limited
TWENTY-FOUR: COMPANY PROFILES: INFORMATION TECHNOLOGY SPECIALISTS
Advaita Bioinformatics
Apple Inc
Cartagenia
Cerner Corp
CLC bio
Cypher Genomics Inc
Dell Healthcare and Life Sciences
Desktop Genetics, Ltd
DNAnexus
Edico Genome
Euformatics Oy
GENALICE
GenomOncology
Google Genomics (Alphabet)
IBM Healthcare
Intel Corporation
Knome Inc
Collaborations
N-of-One
PierianDx
Rennova Health, Inc
Sophia Genetics
Sunquest Information Systems
Tute Genomics
WuXi NextCODE Genomics
TWENTY-FIVE: COMPANY PROFILES: MICROBIOLOGY SPECIALISTS
Accelerate Diagnostics, Inc
Advanced Biological Laboratories, S.A. (ABL)
AdvanDx, Inc
altona Diagnostics
ArcDia International Oy Ltd
BioFire Diagnostics, Inc
Recent Revenue History
Copan Diagnostics Inc
Lab Automation
Partnerships
Swabs
Curetis AG
Fast-Track Diagnostics
Focus Diagnostics, Inc
Genetic Analysis AS
GeneWeave Biosciences, Inc
About Smarticle Technology
Great Basin Scientific, Inc
Greiner Bio-One International GmbH
Preanalytical Products
Hain Lifescience GmbH
Meridian Bioscience, Inc
Recent Revenue History
Immunoassays
illumigene
Meridian Life Science
Sample Collection
Mobidiag Ltd
Nanosphere, Inc
Recent Revenue History
Market Expansion
PositiveID Corporation
Recent Revenue History
Seegene, Inc
Recent Revenue History
Instrumentation
Collaborations
Specific Technologies
Synbiosis Ltd
T2 Biosystems
Recent Revenue History
ViroCyt, LLC
TWENTY-SIX: COMPANY PROFILES: MOLECULAR TEST SPECIALISTS
Agena Bioscience
Market Expansion
Asuragen Inc
Controls
Sample Collection
Sequencing
AutoGenomics Inc
BGI (formerly Beijing Genome Institute)
Prenatal Testing
Liquid Biopsy
With Complete Genomics
BGI Projects
Biocartis Group
Recent Revenue History
Connectivity
DMAT Instrumentation - MyCartis
Idylla News
Infectious Diseases
Building the Future
Collaborations
Enzo Biochem Inc
Recent Revenue History
IP Situation
Epigenomics
Exosome Diagnostics, Inc
Fluidigm Corporation
Recent Revenue History
GenMark Diagnostics
Recent Revenue History
Genome Diagnostics BV (GenDx)
Life Technologies Corporation
Instrumentation and Applications
Liquid Biopsy
Sequencing
Life Technologies an IVD company
Emerging Pathogens
Bacterial Typing
Forensic
Nanostring Technologies, Inc
Recent Revenue History
Immunohistochemistry
Alliances
LDTs
Oxford Nanopore Technologies Ltd
Pacific Biosciences of California, Inc. (PacBio)
Recent Revenue History
QuanDx Inc
RainDance Technologies, Inc
Recent Revenue History
Market Expansion
Rubicon Genomics, Inc
Transgenomic, Inc
Alliances
Lab Services
Diagnostic Tools Division
TrovaGene, Inc
Vela Diagnostics
WaferGen Bio-systems, Inc
Recent Revenue History
TWENTY-SEVEN: COMPANY PROFILES: POINT OF CARE TEST
SPECIALISTS
Abaxis, Inc
Recent Revenue History
Abingdon Health Ltd
Atlas Genetics Ltd
Biomeme, Inc
Chembio Diagnostic Systems, Inc
Recent Revenue History
DNA Electronics Ltd (DNAe)
Enigma Diagnostics Limited
Entopsis
Epistem Holdings plc
FABPulous B.V
Fio Corporation
Hema Diagnostic Systems (HDS)
Imec
InSilixa Inc
MedMira Inc
OraSure Technologies, Inc
Recent Revenue History
The Genotek Business
PTS Diagnostics
QloudLab SA
QuantuMDx Group Limited
Rheonix, Inc
Samsung Healthcare
Scanadu, Inc
Theranos, Inc
Veredus Laboratories Pte Ltd
Xagenic
TWENTY-EIGHT: COMPANY PROFILES: PRENATAL TEST SERVICE PROVIDERS
Ariosa Diagnostics, Inc
Berry Genomics Co. Ltd
Combimatrix Corp
Recent Revenue History
Good Start Genetics, Inc
Illumina
IP Issues
Cytogenetics
Inex Innovations Exchange
LifeCodexx AG
MAP Diagnostics Ltd
Multiplicom N.V
Natera
Recent Revenue History
Oncology – Planning for the Future
Premaitha Health plc
Sequenom Inc
Recent Revenue History
Market Expansion
Product Expansion
IP Issues
Oncology
Coagulation
TWENTY-NINE: COMPANY PROFILES: QUALITY CONTROL & SAMPLE PRETREATMENT SPECIALISTS
Horizon Discovery Group plc
Recent Revenue History
Collaborations
MO BIO Laboratories, Inc
Oasis Diagnostics Corporation
PreAnalytiX GmbH
SeraCare Life Sciences, Inc
Streck Inc
THIRTY: COMPANY PROFILES: TEST SERVICE PROVIDERS
23andMe
The Move to Building a Research Company
Therapeutics Group
Ancestry
Outside the U.S
Agendia BV
Recent Revenue History
Ambry Genetics
Epilepsy
Oncology
Cardiac
Prenatal
Information Technology
ARUP Laboratories
Assurex Health
BioCollective (The)
Bio-Reference Laboratories, Inc. (BRLI)
bioTheranostics
BluePrint Genetics Oy
Boston Heart Diagnostics
CareDx, Inc. (Formerly XDx, Inc.)
Recent Revenue History
Sequencing
Cleveland HeartLab Inc
Counsyl
Eurofins Genomics
Exact Sciences Corp
Recent Revenue History
Foundation Medicine Inc
Recent Revenue History
Collaborations
Genomic Health, Inc
Recent Revenue History
Market Uptake
Liquid Biopsy
Service Spin-off
Genomic Vision
Recent Revenue History
Helomics Corporation (formerly Precision Therapeutics, Inc)
Mayo Medical Laboratories
Information Technology
MDxHealth SA
Recent Revenue History
OPKO Diagnostics
Pathway Genomics Corporation
Rosetta Genomics Ltd
Recent Revenue History
Expansion
Sonic Healthcare
Recent Revenue History
Veracyte, Inc
Recent Revenue History
Vermillion Inc
Recent Revenue History
List of Exhibits
ONE: EXECUTIVE SUMMARY
Table 1-1
Exchange Rate Fluctuations, 2012–2016
Table 1-2
Worldwide In Vitro Diagnostic Reagent Sales by Market Segment, 2016-2021
TWO: INTRODUCTION
Table 2-1
Worldwide In Vitro Diagnostic Sales by Product Market, 2016-2021
Table 2-2
Selected Diagnostics Industry Acquisitions, 2014, 2015 and H2 2016
Table 2-3
Selected Diagnostics Industry Distribution Agreements, 2014, 2015, H2 2016
Table 2-4
Selected IVD collaboration/Licensing Agreements, 2014, 2015, H2 2016
Table 2-5
Selected Test Services, Sales 2012-2016
Table 2-6
Lab Market Segmentation, Worldwide, 2016
Table 2-7
Revenues for a Selection of U.S.-based Reference Labs, 2012-2016
Table 2-8
Selected Company sponsored Labs Established in 2014 and 2015
Table 2-9
Revenues of Selected Top IVD Companies, 2012-2016
Table 2-10
Revenues of Selected Niche Players, 2012-2016
Table 2-11
IVD Test Segment Sales 1995-2015
THREE: OVERVIEW OF GLOBAL IN VITRO DIAGNOSTIC MARKETS
Table 3-1
World Population Distribution, 2016
Table 3-2
Selected Disease Statistics, Worldwide
Table 3-3
Elderly Support Ratio in Selected Countries (2050)
Table 3-4
Available Market Data, 2016
Table 3-5
Worldwide In Vitro Diagnostic Reagent Sales by Country/Region, 2016-2021
Figure 3-1
EU IVD Revenue Stream 2007-2016
Table 3-6
European Union (EU14) IVD Sales by Country 2014
Table 3-7
Per Capita IVD Expenditure
FOUR: TRENDS AND INNOVATION
Table 4-1
Selected Sequencing Platforms
Table 4-2
Selected IVD industry IT Investments
Table 4-3
Selected Gene Editing Research Kits
Table 4-4
Selected Wearable Devices
Table 4-5
Selected Disease Markers in Exhaled Breath
Table 4-6
Selected Breath Test Innovations
FIVE: POINT-OF-CARE TESTS
Table 5-1
Professional POC Test Sales by Category, Worldwide, 2016-2021
Table 5-2
Hospital POC Test Usage, U.S
Table 5-3
Selected Profession POC Test Innovations
Table 5-4
POC Self Test Sales by Category, Worldwide, 2016-2021
Table 5-5
POC Test Revenues of Selected IVD Companies, 2013-2015
Table 5-6
Selected Apps and Glucose Management IT
Table 5-7
Diabetes Sales by Test Category, Worldwide, 2016-2021
Table 5-8
World Glucose Monitoring Sales, Major Companies, 2012-2016
Table 5-9
Selected Glucose Self-Test Meter Innovations
Table 5-10
Selected Noninvasive Glucose Monitoring Devices
Table 5-11
Selected Continuous BGM Sales, 2013 – 2016
Table 5-12
Selected Continuous Blood Glucose System Developments
Table 5-13
Selected Innovations in Hospital-based Glucose Monitoring
Table 5-14
Selected POC HbA1c Devices
Table 5-15
Selected POC Diabetes Monitoring Tests
SIX: THE CORE LAB
Table 6-1
Workstation Sales, 2016-2021 (General Chemistries, Immunos on workstations)
Table 6-2
Core Lab Sales of the Top Five Manufacturers, 2012-2016
Table 6-3
Selected New Analytes for the Core Lab, 2014-2015
Table 6-4
Selected Lab Automation Innovations
Table 6-5
Worldwide Clinical Chemistry Sales by Test Category, 2016-2021
Table 6-6
Major Clinical Chemistry Companies
Table 6-7
Selected Clinical Chemistry Innovations
Table 6-8
Major Whole Blood Chemistry Analyzers
Table 6-9
Selected Apps, Critical Care and Urinalysis IT Innovations, 2016
Table 6-10
Selected Urinalysis Innovations, 2016
SEVEN: IMMUNOASSAYS
Table 7-1
Selected New Immunoassay Technologies, 2016
Table 7-2
Selected Innovation in Mass Spectrometry for Routine Analyses
Table 7-3
Selected Immunoassay Innovations on Core Lab Instruments
Table 7-4
Worldwide Lab-based Immunoassay Sales by Analyte Type, 2016-2021
Table 7-5
Selected Immunoassay Quality Control Products
Table 7-6
Revenue History of Leading Immunoassay Vendors, 2012-2016
Table 7-7
Selected New Vitamin D Immunoassays, 2014-2016
Table 7-8
Selected Tumor Marker Innovations, 2014-2016
Table 7-9
Selected Cardiac Marker Innovations
Table 7-10
Selected Autoimmune Test Innovations
Table 7-11
Selected Arthritis Immunoassay Innovations
Table 7-12
Selected Inflammatory Bowel Disease Test Innovations
Table 7-13
Selected Immunoassays for Transplant Medicine
Table 7-14
Selected Women’s Health Innovations
Table 7-15
Selected Innovations for Alzheimer’s Disease Immunoassays
Table 7-16: Selected Immunoassay Innovations
Table 7-17
POC Immunoassay Test Sales by Test Category, 2016-2021
Table 7-18
Selected Self-Test Immunoassay Innovations
Table 7-19
Selected Professional POC Test Innovations, 2016
Table 7-20
Selected POC Immunoassay Test Platforms
EIGHT: MOLECULAR ASSAYS 310
Table 8-1
Common Next Generation Molecular Test Traits
Table 8-2
Selected Molecular Test Sample Preparation and QC Innovations
Table 8-3
Selected Exosome Test Innovations
Table 8-4
Selected Liquid Biopsy Innovations
Table 8-5
Selected IT Innovations in Molecular Diagnostics
Table 8-6
Selected Innovations in Forensic DNA Testing
Table 8-7
Key Molecular Technologies and Major Players
Table 8-8
Selected Molecular Test Platform Innovations
Table 8-9
Molecular Test Revenues of Selected IVD Vendors, 2012-2016
Table 8-10
Worldwide Molecular Test Sales by Type, 2016-2021
Table 8-11
Selected Molecular Tumor Marker Test Innovations
Table 8-12
Most Frequently Requested Genetic Tests
Table 8-13
Selected Genomic Tests for Inherited Diseases
Table 8-14
Revenue Stream of Selected NIPT Service Companies, 2012-2015
Table 8-15
Prenatal Services Provided
Table 8-16
Selected Molecular Tests for Prenatal Analysis
Table 8-17
Selected HLA Typing Test Innovations
NINE: HEMATOLOGY
Table 9-1
CellaVision Placement Data by Hematology Vendor
Table 9-2
Selected Hematology Image Analysis Innovations, 2014-2015
Table 9-3
Selected POC Hematology Innovations
Table 9-4
Revenue History of the Major Hematology Vendors, 2012-2016
Table 9-5
Selected Hematology Innovations, 2016
TEN: COAGULATION
Table 10-1
Worldwide Coagulation Sales by Segment, 2016-2021
Table 10-2
Selected Lab-based Coagulation Innovations, 2016
Table 10-3
Selected Molecular Coagulation Test Innovations
Table 10-4
Selected POC Coagulation Test Innovations
Table 10-5
Top Coagulation Company Revenues, Lab & POC, 2012 – 2016
Table 10-6
Major Anticoagulants Uses and Tests
ELEVEN: MICROBIOLOGY AND VIROLOGY
Table 11-1
Global Deaths from Communicable Diseases, 2010
Table 11-2
Selected Tests for Emerging Pathogens
Table 11-3
Selected Tests for Antibiotic Resistance
Table 11-4
Selected Microbiology Mass Spec Innovations
Table 11-5
Selected Microbiome-based Tests
Table 11-6
Worldwide Microbiology/Virology Sales by Type, 2016-2021
Table 11-7
Selected Innovations in Microbiology Pre-Analytical Products
Table 11-8
Selected Innovations in Bacterial Identification
Table 11-9
Selected Antibiotic Sensitivity Test Innovations
Table 11-10
Revenue of Selected Microbiology Companies, 2013, 2016
Table 11-11
Selected Advanced Techniques for Positive Blood Cultures
Table 11-12
Lab-based Infectious Disease Immunoassays, by Test, 2016
Table 11-13
Selected Infectious Disease Immunoassay Innovations
Table 11-14
Selected Professional Use POC Tests for Infectious Diseases
Table 11- 15: Selected Molecular Test Platform Innovations, 2014-2016
Table 11-16
Selected Microbiology Sequencing Innovations
Table 11-17
Molecular Test Sales, Infectious Diseases, 2016
Table 11-18
Selected Molecular HAI Test Innovations
Table 11-19
Selected Molecular Tests for STDs
Table 11-20
Selected Molecular Respiratory Disease Innovations
Table 11-21
Selected Molecular HIV Test Innovations
Table 11-22
Selected Infectious Disease Molecular Test Innovations
Table 11-23
Selected Molecular POC Device Innovations
TWELVE: BLOOD BANKING SERVICES
Table 12-1
Blood Donation, Key Facts
Table 12-2
Distribution of Blood Units Collected
Table 12-3
Laboratory Screening of Blood Donations for Transfusion-Transmissible Infections, Number of Countries (Syphilis, HCV, HBV, HIV)
Table 12-4
Blood Component Usage (Liver Transplant, Adult Open Heart Surgery, Automobile Accident, Leukemia, Sickle Cell Disease, Cancer Chemotherapy)
Table 12-5
Impact of Alloimmunization (% of Patients Screening Positive for One or More Antibodies)
Table 12-6
Worldwide Blood Bank Sales, 2016-2021
Table 12-7
Selected Blood Grouping Innovations
Table 12-8
Selected New Blood Screen NAT Tests and Systems
THIRTEEN: HISTOLOGY AND CYTOLOGY
Table 13-1
Selected Histology Lab Automation
Table 13-2
Histology Information Technology Tools
Table 13-3
Selected Advanced Histology Techniques
Table 13-4
Selected HPV Test Innovations
Table 13-5
Worldwide Histology/Cytology Sales by Type, 2016-2021
Table 13-6
Revenues of the Major Histology Companies, 2012-2016
Table 13-7
Selected Vendors Of Traditional Histology Stains
Table 13-8
Selected In Situ Hybridization-based Tests
Table 13-9
Selected IHC Test Innovations
Table 13-10
Major Pharmacodiagnostic Markers
Table 13-11
Selected Pharmacodiagnostic Histology Tests
Table 13-12
Selected Digital Imaging Innovations
Table 13-13
Selected Innovations in CTC Technology

--UNITED STATES IVD MARKET ---
1: Executive Summary
Introduction
Market Metrics – Utilization
Market Metrics – Aging
Market Metrics – Disease
Market Metrics – U.S. Total Health and Clinical Lab Expenditures and Payers
Market Metrics – U.S. Clinical Testing by Channel
Impacts of the Affordable Care Act
Impacts of PAMA and LDT Reform
U.S. IVD Market
Top Tier U.S. IVD Market Participants and Rankings
Conclusions
2: Introduction to U.S. Health Care
The United States and In Vitro Diagnostics
U.S. Patient Population
Healthcare System Utilization
Aging
Disease Prevalence and Incidence
Health Insurance in the United States and the Affordable Care Act
U.S. Health Expenditure
U.S. Clinical Lab Expenditure
Affordable Care Act (ACA)
Clinical Testing under Medicare – Reimbursement Cuts and Market-Based Pricing 55
Protecting Access to Medicare Act of 2014 (PAMA)
Molecular Diagnostics and Medicare Policy
Laboratory-Developed Tests (LDTs) Invigorate Market, Challenge Regulators
U.S. Healthcare Infrastructure and Testing Channels
Hospitals
Independent Labs
Physician Office Laboratories
Self-Testing
Retail Clinics
Conclusions
3: U.S. IVD Market Analysis
Clinical Chemistry
Microbiology and Virology – ID/AST and Molecular
Point-of-Care Testing
Immunoassays
Urinalysis
Molecular Diagnostics
Coagulation
Histology
Hematology
Blood Testing and Typing
Flow Cytometry
Total U.S. IVD Market
4: Top Tier U.S. IVD Market Players
Abbott Diagnostics
Core Lab
Hematology
Molecular
Blood Testing
Mass Spectrometry ID/AST
Diabetes Testing
Point-of-Care (POC) Diagnostics
Alere
Critical Care
Lipids and Cardiac Markers
Diabetes Testing
Coagulation
Toxicology / Drugs of Abuse
Infectious Diseases
Beckman Coulter (Danaher)
Immunoassays
Clinical Chemistry
Hematology
Microbiology
Urinalysis
Flow Cytometry
Molecular
Becton, Dickinson and Company (BD)
Microbiology
Mass Spectrometry
Immunoassays
Molecular
Histology/Cytology
Flow Cytometry
bioMérieux
Microbiology
Mass Spectrometry
Immunoassays
Molecular
Sequencing
Bio-Rad Laboratories
Microbiology
Hemoglobinopathy and Diabetes Testing
Immunoassays
Blood Typing and Testing
Tissue Typing
Sequencing
Cepheid
Molecular Hospital-Acquired Infection (HAI) Testing
Molecular Sexual Health and Women’s Health Testing
Molecular Critical Infectious Disease Testing
Molecular Oncology Testing
Danaher Corporation
Histology
Point-of-Care Testing
Hologic
Molecular Cytology / Histology (HPV)
Other Molecular (STIs, HIV, HCV, TB, Respiratory)
Microbiology (AccuProbe Molecular Culture ID Tests)
Blood Testing (Molecular PROCLEIX Tests)
Johnson & Johnson (Incl. Janssen Diagnostics)
Ortho-Clinical Diagnostics
Core Lab
Blood Testing and Typing
QIAGEN
Molecular Infectious Disease
Companion Diagnostics
Immunoassays
Next-Generation Sequencing
Roche Diagnostics
Professional Diagnostics
Immunoassays
Point-of-Care Diagnostics
Diabetes Care
Tissue Diagnostics
Molecular Diagnostics
Blood Testing
Sequencing
Microbiology (GeneWeave)
Siemens Healthcare Diagnostics
Clinical Chemistry
Immunoassays
Hematology
Molecular Diagnostics and Histology
Urinalysis
Coagulation
Point-of-Care Diagnostics
Sysmex Corporation
Hematology
Coagulation
Urinalysis
Thermo Fisher Scientific
Immunoassays
Drug Testing
Histology
Mass Spectrometry
Microbiology
Molecular
Sequencing

L I S T   O F   E X H I B I T S

CHAPTER ONE: EXECUTIVE SUMMARY

  • Table 1-1: U.S. Commercially Insured Members’ Encounters with Ambulatory Physicians (per 1,000 Members) (2005-2014)
  • Table 1-2: Historical and Projected U.S. Aged Populations (60+) (% Share of Total Population, Population in Millions) (1950-2050)
  • Table 1-3: U.S. IVD Market by Segment (2015/2020)
  • Table 1-4: U.S. IVD Market Rankings by Estimated 2015 Revenue – Top 15 Companies
  • CHAPTER TWO: INTRODUCTION

  • Figure 2-1: U.S. IVD Market (2015/2020)
  • Table 2-1: U.S. Hospital Inpatient Admissions and Outpatient Visits Per 1,000 Persons (1994-2013)
  • Table 2-2: U.S. Commercially Insured Members’ Encounters with Ambulatory Physicians (per 1,000 Members) (2005-2014)
  • Table 2-3: Historical and Projected U.S. Aged Populations (60+) (% Share of Total Population, Population in Millions) (1950-2050)
  • Table 2-4: U.S. Cancer Incidence – Aggregate, Lung, Colon, Prostate, Breast (per 100,000 persons) (2002-2012)
  • Table 2-5: Selected Notifiable Infectious Disease Incidences in the United States (per 100,000 persons) (2003-2013)
  • Table 2-6: U.S. National Health Expenditure by Payer (Out-of-Pocket, Private Health Insurance, Medicare, Medicaid) (2013-2020)
  • Table 2-7: U.S. Clinical Laboratory Market by Segment - Hospital, Independent, Physician Office (2013-2020)
  • Figure 3-1: U.S. Clinical Chemistry Market (2015/2020)
  • Figure 3-2: U.S. ID/AST Microbiology Market (2015/2020)
  • Figure 3-3: U.S. Molecular Microbiology / Virology Market (2015/2020)
  • CHAPTER THREE: MARKET ANALYSIS

  • Table 3-1: U.S. ID/AST Microbiology Market – Automated ID/AST, Manual/Semi-Auto ID/AST, Blood Culture, Chromogenic Media, Rapid Micro (2015/2020)
  • Table 3-2: U.S. Molecular Microbiology / Virology Market – HAIs/BSIs, HIV, Hepatitis, CT/NG, HPV, Respiratory, Mycobacteria/TB, Other (2015/2020)
  • Figure 3-4: U.S. Point-of-Care (POC) Diagnostics Markets – Professional, OTC Diabetes, OTC Other (2015/2020)
  • Table 3-3: U.S. Point-of-Care (POC) Diagnostics Markets – Professional (Drugs of Abuse, Infectious Disease, Pregnancy, Glucose, HbA1c, Lipids, Cardiac Markers, FOB, Critical Care, Coagulation, Hematology, Other), OTC Diabetes, OTC Other (2015/2020)
  • Figure 3-5: U.S. Immunoassays Markets – Infectious and Non-Infectious (2015/2020)
  • Table 3-4a: U.S. Immunoassays Market – Non Infectious (Cardiac Markers, Tumor Markers, HbA1c, Autoimmune, Allergy, Thyroid, Proteins, Anemia, Fertility, Therapeutic Drugs, Drugs of Abuse, Vitamin D) (2015/2020)
  • Table 3-4b: U.S. Immunoassays Market – Infectious (Hepatitis, HIV, STDs, ToRCH, Respiratory, HAIs/Sepsis, Parasitology, Mycology, Others)
  • Figure 3-6: U.S. Urinalysis Lab Diagnostics Market (2015/2020)
  • Figure 3-7: U.S. Molecular Diagnostics Market (2015/2020)
  • Figure 3-8: U.S. Coagulation Diagnostics Market (2015/2020)
  • Figure 3-9: U.S. Histology and Cytology Diagnostics Market (2015/2020)
  • Figure 3-10: U.S. Hematology Diagnostics Market (2015/2020)
  • Figure 3-11: U.S. Blood Testing and Typing Diagnostics Market (2015/2020)
  • Figure 3-12: U.S. Clinical Flow Cytometry Market (2015/2020)
  • Table 3-5: U.S. IVD Market by Segment (2015/2020)
  • CHAPTER FOUR: COMPANY PROFILES

  • Table 4-1: Abbott Diagnostics Revenue (2012-2015)
  • Table 4-2: Alere Revenue (2012-2015)
  • Table 4-3: Beckman Coulter Revenue (2012-2015)
  • Table 4-4: BD Revenue (FY 2012-FY 2015)
  • Table 4-5: bioMérieux Revenue (2012-2015)
  • Table 4-6: Bio-Rad Laboratories Revenue (2012-2015)
  • Table 4-7: Cepheid Revenue (2012-2015)
  • Table 4-8: Danaher Diagnostics Group Subsidiary Revenue (Beckman Coulter, Radiometer, Leica Biosystems) (2012-2015)
  • Table 4-9: Hologic Revenue (FY 2012-FY 2015)
  • Table 4-10: Johnson & Johnson Diagnostics Revenue (2012-2015)
  • Table 4-11: QIAGEN Revenue (2012-2015)
  • Table 4-12: Roche Diagnostics Revenue (2012-2015)
  • Table 4-13: Siemens Healthcare Diagnostics Revenue (FY 2012-FY 2015)
  • Table 4-14: Sysmex Corporation Revenue (FY 2012-FY 2015)
  • Table 4-15: Thermo Fisher Scientific Revenue (2012-2015)


    --COMPANION DIAGNOSTIC TESTING -- 

    ONE: EXECUTIVE SUMMARY
    Overview
    Scope and Methodology
    Market Overview
    Prognosis for Growth
    TWO: INTRODUCTION
    Terms Used in Companion Diagnostics and Personalized Medicine
    Definitions of Companion Diagnostics and Personalized Medicine Used in This Report
    Types of Tests Included in Personalized Medicine
    Technology Used in Personalized Medicine
    Point of View
    THREE: CURRENT AND EMERGING APPLICATIONS OF PERSONALIZED MEDICINE
    Oncology (Solid Tumors and Hematological Cancers)
    Cardiovascular Disease
    Neurological Disorders
    Autoimmune and Inflammatory Disorders; Other Immune Related Conditions
    Infectious Disease
    Antibiotic Resistance
    Other Infectious Disease Personalized Medicine Tests
    Therapeutic Drug Monitoring
    Drug Metabolism
    Other Applications of Personalized Medicine Tests
    FOUR: BUSINESS MODELS AND DEALS – PERSONALIZED MEDICINE AND COMPANION DIAGNOSTICS
    Business Models
    Business Models for Pharmaceutical Companies in Personalized Medicine
    Business Models for Diagnostic Companies in Personalized Medicine
    Investments and Financing Agreements
    Mergers and Acquisitions
    Collaborations between Pharmaceutical and Diagnostic Companies
    Other Pharmaceutical Company Agreements
    Diagnostic Company Collaborations with Other (Non-Pharmaceutical) Companies
    Diagnostic Company Collaborations with Universities and Non-Profit Research
    Institutes
    FIVE: PERSONALIZED MEDICINE AND COMPANION DIAGNOSTICS – MARKET DRIVERS AND CHALLENGES
    Cancer Diagnostic Market Drivers
    Companion Diagnostic Tests in Drug Development – Opportunities and Challenges
    Clinical Validation of Novel Biomarkers or Genetic Signatures
    Regulation of Companion Diagnostics
    Complexities of Companion Diagnostic Tests and Corresponding Therapeutic
    Products; Harmonization of Companion Diagnostic Tests across a Class of Targeted
    Therapies
    Guidelines
    Laboratory Developed Tests and the FDA
    Limited Tissue from Biopsies for Growing Number of Cancer Tests
    Advances in Technology Changing the Future of Personalized Medicine Diagnostics .. 277
    Reimbursement
    Physician Education, Acceptance, and Use of Novel Personalized Medicine Tests
    Competition
    Working Together on Personalized Medicine – Alliances, Consortiums, and Other
    Groups
    Future Prospects
    SIX: PERSONALIZED MEDICINE AND COMPANION DIAGNOSTICS – MARKET ANALYSIS
    Global Personalized Medicine and Companion Diagnostic Test Market by
    Geographical Region
    Personalized Medicine and Companion Diagnostic Test Market by Disease
    Indication
    Personalized Medicine Testing Services Market
    SEVEN: COMPANY PROFILES: PHARMACEUTICAL COMPANIES (FOCUSINGON COMPANION DIAGNOSTIC ACTIVITIES)
    AbbVie Inc.
    Recent Revenue History
    Companion Diagnostics/Personalized Medicine Activities
    Acumen Pharmaceuticals, Inc.
    Adaptimmune Therapeutics plc
    Recent Revenue History
    Company Overview
    Amgen Inc.
    Recent Revenue History
    Companion Diagnostics/Personalized Medicine Activities
    ARCA biopharma, Inc.
    Recent Revenue History
    Company Overview
    ARIAD Pharmaceuticals, Inc.
    Recent Revenue History
    Companion Diagnostics/Personalized Medicine Activities
    Arno Therapeutics, Inc.
    Recent Revenue History
    Company Overview
    Array BioPharma Inc.
    Recent Revenue History
    Company Overview
    Astellas Pharma Inc.
    Recent Revenue History
    Companion Diagnostics/Personalized Medicine Activities
    AstraZeneca
    Recent Revenue History
    Companion Diagnostics/Personalized Medicine Activities
    Athera Biotechnologies AB
    AVEO Oncology
    Recent Revenue History
    Company Overview
    Bayer AG
    Recent Revenue History
    Companion Diagnostics/Personalized Medicine Activities
    Boehringer Ingelheim
    Recent Revenue History
    Companion Diagnostics/Personalized Medicine Activities
    Bristol-Myers Squibb Company
    Recent Revenue History
    Companion Diagnostics/Personalized Medicine Activities
    Celldex Therapeutics, Inc.
    Recent Revenue History
    Company Overview
    Clovis Oncology, Inc.
    Recent Revenue History
    Companion Diagnostics/Personalized Medicine Activities
    Eli Lilly
    Recent Revenue History
    Companion Diagnostics/Personalized Medicine Activities
    Galena Biopharma, Inc.
    Recent Revenue History
    Company Overview
    GlaxoSmithKline plc
    Recent Revenue History
    Companion Diagnostics/Personalized Medicine Activities
    Idera Pharmaceuticals, Inc
    Recent Revenue History
    Company Overview
    Janssen Pharmaceutical Companies of Johnson & Johnson
    Merck & Co., Inc.
    Recent Revenue History
    Companion Diagnostics/Personalized Medicine Activities
    Merck KGaA (EMD Serono)
    Novartis AG
    Recent Revenue History
    Companion Diagnostics/Personalized Medicine Activities
    Pfizer Inc.
    Recent Revenue History
    Companion Diagnostics/Personalized Medicine Activities
    Roche (F. Hoffmann-La Roche Ltd.) and Genentech (A Member of the
    Roche Group)
    Recent Revenue History
    Companion Diagnostics/Personalized Medicine Activities
    EIGHT: COMPANY PROFILES: DIAGNOSTIC COMPANIES AND CLINICAL LABORATORIES
    20/20 GeneSystems, Inc
    A&G Pharmaceutical, Inc.
    Abacus Diagnostica Oy
    Abbott Laboratories
    Recent Revenue History
    Company Overview – Focusing on Personalized Medicine and Companion
    Diagnostics
    Agreements with Pharmaceutical Companies
    Acquisitions and Other Agreements with Other Companies
    Accelerate Diagnostics, Inc.
    Recent Revenue History
    Company Overview
    Acobiom
    ACT Genomics Co., Ltd.
    Adaptive Biotechnologies Corporation
    Admera Health (A GENEWIZ Company)
    Advanced Cell Diagnostics
    Products
    Services for Pharmaceutical Companies
    Companion Diagnostics Agreements
    Aelan Cell Technologies
    Affymetrix, Inc. (Acquired by Thermo Fisher Scientific)
    Recent Revenue History
    Company Overview
    eBioscience
    Affymetrix Core
    Selected Affymetrix Agreements
    Agena Bioscience Inc.
    Agendia NV
    Almac Group Limited
    AltheaDx, Inc.
    Amarantus BioScience Holdings, Inc.
    Amarantus Diagnostics
    Amoy Diagnostics Co., Ltd.
    ANGLE plc
    ARKRAY, Inc.
    Assurex Health, Inc.
    Asuragen, Inc.
    Diagnostic Products
    Translational/Companion Diagnostics
    Agreements
    Atlas Genetics Ltd
    AutoGenomics, Inc.
    Avant Diagnostics, Inc.
    BacterioScan, Inc.
    Beckman Coulter, Inc. (Subsidiary of Danaher Corporation)
    Recent Revenue History
    Company Overview
    Flow Cytometry
    Beckman Coulter Genomics
    Other Tests and Services
    Agreements
    Becton, Dickinson and Company (BD)
    Recent Revenue History
    Company Overview
    Microbiology and Molecular Diagnostic Testing for Infectious Diseases
    Fluorescence-Activated Cell Sorters and Analyzers
    Oncology
    BG Medicine, Inc.
    Recent Revenue History
    Company Overview
    Biocartis
    Recent Revenue History
    Company Overview
    Startup History
    Technology/Products
    Investors/Financings and IPO
    Pharmaceutical Company Agreements
    Other Agreements
    Biocept, Inc.
    Recent Revenue History
    Company Overview
    Financings
    Agreements with Pharmaceutical Companies
    Other Agreements
    Biodesix, Inc.
    Investors/Financings
    Other Agreements
    BioFire Diagnostics, LLC. (Acquired by bioMérieux)
    Recent Revenue History and Other Financial Information
    Company Overview
    BioGenex
    Biological Dynamics, Inc.
    BioMarker Strategies
    bioMérieux SA
    Recent Revenue History
    Company Overview
    Traditional Microbiology
    Immunodiagnostics for Lab Professionals (Clinical Laboratories)
    Mass Spectrometry for Clinical Laboratories
    Molecular Diagnostics
    Selected Pharmaceutical Company Agreements
    Other Agreements
    BioMosaics Inc.
    BioReference Laboratories, Inc. (BRLI) (Part of OPKO Health, Inc.)
    Recent Revenue History
    Company Overview
    bioTheranostics, Inc.
    Biotype Diagnostic GmbH
    Cancer Genetics, Inc.
    Recent Revenue History
    Company Overview
    Pharmaceutical Company Agreements
    Other Agreements
    Caprion, Inc.
    CardioDx, Inc.
    CardioGenics Holdings Inc.
    CareDx, Inc.
    Recent Revenue History
    Company Overview
    Caris Life Sciences
    Castle Biosciences, Inc.
    Cepheid
    Recent Revenue History
    Company Overview
    Clarient Diagnostic Services, Inc. (A NeoGenomics Company)
    Recent Revenue History
    Company Overview
    CompanionDx
    Crescendo Bioscience (A Myriad Company)
    Cube Dx GmbH
    Curetis AG
    Recent Revenue History
    Company Overview
    Cynvenio Biosystems, Inc.
    Dako A/S (An Agilent Company)
    Recent Revenue History
    Company Overview
    Danaher Corporation
    Recent Revenue History
    Company Overview
    Definiens AG (Acquired by MedImmune, Part of AstraZeneca)
    DiaCarta, Inc.
    DiamiR, LLC
    Diatech Pharmacogenetics srl
    Diaxonhit
    Recent Revenue History
    Company Overview
    DNA Electronics Ltd. (DNAe)
    EntroGen, Inc.
    Enzo Biochem, Inc./Enzo Life Sciences, Inc./Enzo Clinical Labs, Inc.
    Recent Revenue History
    Company Overview
    Epic Sciences, Inc.
    Eutropics Pharmaceuticals
    Exosome Diagnostics, Inc.
    Selected Agreements
    Foundation Medicine, Inc.
    Recent Revenue History
    Company Overview
    Pharmaceutical Company Agreements
    Agreement with Contract Research Organization
    Agreements with Universities and Other Non-Profit Institutions
    Agreements with Other (Non-Diagnostic) Companies
    GeneCentric Diagnostics, Inc.
    Genection, Inc. (An Invivoscribe Company)
    Genelex Corporation
    GeneNews Limited and Innovative Diagnostic Laboratory
    Genomas, Inc.
    GenomeDx Biosciences
    Genomic Health, Inc.
    Recent Revenue History
    Company Overview
    Genomica S.A.U.
    Genomind
    Genoptix (A Novartis Company)
    GenPath Oncology
    Grifols, S.A.
    Recent Revenue History
    Company Overview
    Guardant Health, Inc.
    HalioDx
    Harmonyx Diagnostics
    Helomics Corporation
    HTG Molecular Diagnostics, Inc.
    Recent Revenue History
    Company Overview
    Products
    Pharmaceutical Company Agreements
    Selected Other Agreements
    Illumina, Inc.
    Recent Revenue History
    Company Overview
    Products and Services – Overview
    Investing in the Future
    Companion Diagnostics
    Agreements with Pharmaceutical Companies
    Other Companion Diagnostic/Personalized Medicine Agreements
    Inform Genomics, Inc.
    Financings
    Other Agreements
    Inivata Ltd.
    Insight Genetics, Inc.
    Selected Agreements
    InSilixa, Inc.
    IntegraGen SA
    Recent Revenue History
    Company Overview
    Invivoscribe Technologies, Inc.
    Iris BioTechnologies Inc.
    Recent Revenue History
    Company Overview
    Janssen Diagnostics/Janssen Diagnostics BVBA/Janssen Diagnostics, LLC
    Infectious Disease
    Oncology
    Lab 21 (Part of the Novacyt Group of Companies)
    Laboratory Corporation of America (LabCorp)
    Recent Revenue History
    Company Overview
    Selected Examples of Companion Diagnostic/Personalized Medicine Agreements between LabCorp or Covance and Other Diagnostic Companies
    Leica Biosystems Inc. (A Danaher Company)
    Pharmaceutical Company Agreements in Companion Diagnostics and Personalized Medicine
    Other Companion Diagnostic/Personalized Medicine Agreements
    Luminex Corporation
    Recent Revenue History
    Company Overview
    Mayo Medical Laboratories and Mayo Clinic
    Medical & Biological Laboratories Co., Ltd. (MBL)/MBL International
    Corporation
    Recent Revenue History
    Company Overview
    Metabolon, Inc.
    Metamark Genetics, Inc.
    MIODx
    MolecularMD Corporation
    Monogram Biosciences (LabCorp Specialty Testing Group)
    Multiplicom NV
    Myriad Genetics, Inc./Myriad RBM, Inc.
    Recent Revenue History
    Company Overview
    Myriad RBM
    Pharmaceutical Company Agreements
    NanoString Technologies, Inc.
    Recent Revenue History
    Company Overview
    NantOmics (Member of the NantWorks ecosystem of companies)
    NeoGenomics, Inc./NeoGenomics Laboratories
    Recent Revenue History
    Company Overview
    NewGene Ltd.
    New Oncology AG
    NovellusDx
    Nuclea Biotechnologies, Inc.
    OncoDNA SA
    Oncompass GmbH
    OncoPlex Diagnostics (OncoPlexDx)(Part of NantOmics)
    Oncospire Genomics
    One Way Liver S.L. (OWL Metabolomics)
    OPKO Health, Inc./OPKO Diagnostics
    Recent Revenue History
    Company Overview
    BioReference Laboratories
    OPKO Lab and 4Kscore™ Test
    Point-of-Care Diagnostics – Claros 1 Analyzer and Sangia Microfluidic Assay Cassettes 728
    OvaGene Oncology Inc.
    Oxford Cancer Biomarkers Ltd
    Oxford Gene Technology
    Panagene Inc.
    Personal Genome Diagnostics, Inc.
    Protagen AG
    QIAGEN N.V.
    Recent Revenue History
    Company Overview
    QuanDx Inc.
    Quest Diagnostics
    Recent Revenue History
    Company Overview
    Qvella Corporation
    RiboMed Biotechnologies, Inc.
    Roche
    Recent Revenue History
    Company Overview
    Roche Professional Diagnostics
    Molecular Diagnostics
    Tissue Diagnostics
    Next-Generation Sequencing
    Rosetta Genomics Ltd.
    Recent Revenue History
    Company Overview
    Selected Agreements
    Siemens Healthcare Diagnostics/Siemens Clinical Laboratory/Siemens
    Recent Revenue History
    Company Overview
    Symbiodx
    Sysmex Corporation
    Recent Revenue History
    Company Overview
    Theranostics Health Inc. (Acquired by Avant Diagnostics, Inc.)
    Thermo Fisher Scientific, Inc.
    Recent Revenue History
    Company Overview
    Transgenomic, Inc.
    Recent Revenue History
    Company Overview
    TrimGen Corporation
    Trovagene, Inc.
    Recent Revenue History
    Company Overview
    Ventana Medical Systems, Inc. (Member of the Roche Group)
    WOUNDCHEK Laboratories
    LIST OF EXHIBITS
    ONE: EXECUTIVE SUMMARY
    Table 1-1: Worldwide Companion Diagnostic Market, 2015 and 2020
    THREE: CURRENT AND EMERGING APPLICATIONS OF PERSONALIZED MEDICINE
    Table 3-1: FDA Cleared/Approved Companion Diagnostic Tests
    Table 3-2: Selected Major Biomarkers in Oncology Personalized Medicine Tests
    Table 3-3: Selected Companies with Personalized Medicine Tests for Oncology
    Table 3-4: Selected Companies with Personalized Medicine Tests for Cardiovascular Disease/Disorders
    Table 3-5: Selected Companies with Personalized Medicine Tests for Neurological Disorders
    Table 3-6: Selected Companies with Personalized Medicine Tests for Autoimmune and Inflammatory Disorders; Other Immune Related Conditions
    Table 3-7: Selected Biomarkers and Other Tests for Antibiotic Resistance, and Companies Developing/Marketing these Biomarkers
    Table 3-8: Selected Companies with Other Personalized Medicine Infectious Disease Tests
    Table 3-9: Selected Companies with Personalized Medicine Tests for Therapeutic Drug Monitoring of Biological Drugs
    Table 3-10: Pharmacogenomic Biomarkers in Drug Labeling
    Table 3-11: Selected Companies with Personalized Medicine Tests for Drug Metabolism Genes
    Table 3-12: Selected Companies with Other Personalized Medicine Tests
    FOUR: BUSINESS MODELS AND DEALS – PERSONALIZED MEDICINE AND COMPANION DIAGNOSTICS
    Table 4-1: Investments and Financings in Personalized Medicine/Companion
    Diagnostics
    Table 4-2: Selected Examples of Pharmaceutical Companies and Other Companies
    That Invested in Diagnostic Companies in Personalized Medicine
    Table 4-3: Mergers and Acquisitions in Personalized Medicine/Companion
    Diagnostics
    Table 4-4: Selected Examples of Pharmaceutical Companies That Acquired Diagnostic Companies or Have Diagnostic Divisions
    Table 4-5: Collaborations between Pharmaceutical and Diagnostic Companies
    Table 4-6: Selected Examples of Pharmaceutical That Entered into Agreements with Diagnostic Companies
    Table 4-7: Selected Other Pharmaceutical Company Agreements
    Table 4-8: Collaborations between Two Diagnostic Companies
    Table 4-9: Diagnostic Company Agreements with Clinical Laboratories
    Table 4-10: Diagnostic Company Agreements with Other Companies
    Table 4-11: Diagnostic Company Collaborations with Universities and Other Non-Profit Research Institutes (Including Government)
    SIX: PERSONALIZED MEDICINE AND COMPANION DIAGNOSTICS – MARKET ANALYSIS
    Table 6-1: World IVD Companion Diagnostics Test Market (In Vitro Diagnostic Kits) by
    Region (N. America, EU, ROW), 2015-2020
    Table 6-2: World IVD Companion Diagnostics Test Market by Disease Segment, 2015(Cancer, Other)
    Table 6-3: Wo.. 287



    --NEXT-GENERATION SEQUENCING MARKETS --


    Chapter 1: Executive Summary
    Overview
    Scope and Methodology
    Market Overview
    Future Prospects in the Sequencing Market
    Chapter 2: Introduction
    Overview – Next Generation Sequencing Market Is Rapidly Changing
    History of DNA Sequencing
    Point-of-View
    Chapter 3: Sequencing Technology
    Sanger Sequencing
    Next-Generation Sequencing
    Massively Parallel Signature Sequencing (MPSS)
    Pyrosequencing
    454 Technology
    Sequencing by Synthesis (SBS)
    Supported Oligonucleotide Ligation and Detection (SOLiD)
    Ion Torrent Sequencing
    Single Molecule Real Time (SMRT) Sequencing
    DNA Nano Ball Sequencing
    Nanopore Sequencing
    Other Sequencing Technologies
    Sequencing Applications/Types of Sequencing
    Sample or Library Preparation
    Information Technology
    Sample-to-Answer (Sample-to-Insight) Workflows or Platforms
    Rapid Next Generation Sequencing Testing
    Chapter 4: Sequencing Applications
    Research, Drug Discovery and Development
    Clinical Diagnostic Applications of Sequencing
    Cancer Diagnostics: NGS Based Tests for Oncology
    Cancer Diagnostics: Liquid Biopsies
    Genetic Analysis – Inherited Disorders, Prenatal and Postnatal Diagnostics
    Infectious Disease Diagnostics
    Human Leukocyte Antigen (HLA) Testing
    Other Diagnostic Applications of Sequencing
    Direct-to-Consumer Genetic Testing Industry
    Chapter 5: Deals – Next Generation Sequencing Companies
    Investments and Financing Agreements
    Mergers and Acquisitions
    Other Corporate Agreements and Collaborations
    Collaborations/Agreements with Diagnostic Companies and/or Clinical Laboratories
    Collaborations/Agreements with Pharmaceutical and Biopharmaceutical Companies
    Collaborations/Agreements between Two Companies in Next Generation Sequencing
    Other Company Collaborations/Agreements
    Collaborations and Other Agreements with Universities, Non-Profit Research Institutes and Government
    Chapter 6: Applying Sequencing to Diagnostics – Market Drivers and Challenges
    Overcoming Technology Hurdles – Sample Preparation and Data Analysis
    Advances in Next Generation Sequencing Platforms
    Next Generation Sequencing Market Drivers
    Advances in Technology
    Research Market Drivers
    Increasing Number of Clinical Applications for Next Generation Sequencing
    Cancer Diagnostic Market Drivers
    Genetic Analysis [Inherited Disorders, Prenatal and Postnatal Diagnostics] Market Drivers
    Infectious Disease Diagnostic Market Drivers
    Market Drivers for Other Segments of the Diagnostic Market
    Issues and Hurdles Faced by NGS Companies Selling to the Research Market
    Issues and Hurdles Faced by Clinical Laboratories Doing NGS
    Regulation of Next Generation Sequencing-Based In Vitro Diagnostic (IVD) Tests
    Regulation of Companion Diagnostics
    Complexities of Companion Diagnostic Tests and Corresponding Therapeutic Products; Harmonization of Companion Diagnostic Tests Across a Class of Targeted Therapies
    Cost and Reimbursement Issues
    Competition
    Future Prospects
    Chapter 7: Sequencing Market Analysis
    Sequencing Market Overview
    Sequencing Market – Geographical Distribution
    Brand Ownership
    Sequencing Market – Research versus Clinical Use
    Sequencing Methods/Applications
    Clinical Sequencing Market – Disease Indications
    Analysis of Deals Activity in Next Generation Sequencing
    Chapter 8: Company Profiles - Next Generation Sequencing Companies
    10x Genomics, Inc.
    23andMe, Inc.
    Abbott Laboratories
    Recent Revenue History
    Company Overview – With a Focus on Sequencing
    ACT Genomics Co., Ltd.
    Adaptive Biotechnologies Corporation
    Admera Health
    Advanced Biological Laboratories (ABL), S.A
    Agilent Technologies Inc.
    Recent Revenue History
    Company Overview
    AltheaDx, Inc.
    Ambry Genetics Corp.
    Aperiomics, Inc.
    Asuragen, Inc.
    Athena Diagnostics, Inc. (A Quest Diagnostics Business)
    Base4 Innovation Ltd
    Beckman Coulter, Inc. (Subsidiary of Danaher Corporation)
    Revenue History
    Company Overview
    Becton, Dickinson and Company (BD)
    Recent Revenue History
    Company Overview
    BGI
    Bina Technologies, Inc. (Part of Roche Sequencing)
    BioDiscovery, Inc.
    Biomatters Ltd.
    bioMérieux SA
    Recent Revenue History
    Company Overview
    bioTheranostics, Inc.
    Cancer Genetics, Inc.
    Recent Revenue History
    Company Overview
    CareDx, Inc.
    Recent Revenue History
    Company Overview
    Caris Life Sciences
    CLC bio (A QIAGEN Company)
    Color Genomics, Inc.
    Complete Genomics (A BGI Company)
    Courtagen Life Sciences, Inc.
    Cynvenio Biosystems, Inc.
    DNA Electronics Ltd.
    Eurofins Genomics
    Exosome Diagnostics, Inc.
    Foundation Medicine, Inc.
    Recent Revenue History
    Company Overview
    GATC Biotech AG
    GenapSys, Inc.
    GenDx
    GENEWIZ Inc.
    Genia Technologies, Inc. (Part of Roche Sequencing)
    Genomic Health, Inc.
    Recent Revenue History
    Company Overview
    Genoptix (A Novartis Company)
    GnuBIO, Inc. (A Bio-Rad Company)
    GRAIL
    Guardant Health, Inc.
    Helix
    HTG Molecular Diagnostics
    Recent Revenue History
    Company Overview
    Human Longevity, Inc.
    Illumina, Inc.
    Recent Revenue History
    Company Overview
    Inivata Ltd.
    Invitae Corporation
    Recent Revenue History
    Company Overview
    Invivoscribe Technologies, Inc.
    Laboratory Corporation of America (LabCorp)
    Recent Revenue History
    Company Overview
    Lasergen, Inc.
    MolecularMD Corporation
    Myriad Genetics, Inc.
    Recent Revenue History
    Company Overview
    NANTOMICS (Member of the NantWorks ecosystem of companies)
    Natera, Inc.
    NeoGenomics, Inc./NeoGenomics Laboratories
    Recent Revenue History
    Company Overview
    N-of-One, Inc.
    OncoDNA SA
    Oncospire Genomics
    Oxford Nanopore Technologies Ltd.
    Pacific Biosciences of California, Inc.
    Recent Revenue History
    Company Overview
    Pathway Genomics Corporation
    Personal Genome Diagnostics, Inc.
    Personalis, Inc.
    QIAGEN N.V.
    Recent Revenue History
    Company Overview
    Quest Diagnostics
    Recent Revenue History
    Company Overview
    RainDance Technologies, Inc.
    Roche
    Recent Revenue History
    Company Overview
    Siemens Healthcare Diagnostics
    Recent Revenue History
    Company Overview
    Stratos Genomics Inc.
    Sysmex Corporation
    Recent Revenue History
    Company Overview
    Thermo Fisher Scientific, Inc.
    Recent Revenue History
    Company Overview
    List of Exhibits
    1: Executive Summary
    Table 1-1: Worldwide Sequencing Market Product Revenues (Instruments and Consumables), 2015 and 2020
    3: Sequencing Technology
    Table 3-1: Current and Emerging Sequencing Technologies and Platforms
    Table 3-2: Selected Companies Developing/Marketing Products for NGS Sample or Library Preparation
    Table 3-3: Selected Companies Developing/Marketing NGS Information Technology Solutions
    Table 3-4: Selected Companies Developing NGS Sample-to-Answer(Sample-to-Insight) Platforms
    Table 3-5: Selected Companies Developing Rapid NGS Assays or Platforms
    4: Sequencing Applications
    Table 4-1: Selected Companies Offering Products/Services for Applications of Next Generation Sequencing in Oncology
    Table 4-2: Selected Companies Developing and/or Marketing Liquid Biopsy Assays
    Table 4-3: Selected Companies Offering Products/Services for Applications of Next Generation Sequencing in Genetic Analysis [Inherited Disorders,Prenatal and Postnatal Diagnostics]
    Table 4-4: Selected Companies Offering Products/Services for Applications of Next Generation Sequencing in Infectious Diseases
    Table 4-5: Selected Companies Offering Products/Services for Applications of DNA Sequencing in Human Leukocyte Antigen (HLA) Testing
    Table 4-6: Selected Companies Offering Products/Services for Applications of Next Generation Sequencing in Other Diagnostic Applications
    5: Deals – Next Generation Sequencing Companies
    Table 5-1: Selected Investment and Financing Agreements in Next Generation Sequencing Companies [Includes IT Companies in NGS]
    Table 5-2: Selected Acquisitions of Next Generation Sequencing Companies[Includes IT Companies in NGS]
    Table 5-3: Selected Agreements between Next Generation Sequencing Companies and Diagnostic Companies or Clinical Laboratories [Includes IT Companies in NGS]
    Table 5-4: Examples of Diagnostic Companies and Clinical Laboratories That Have Made Agreements in Next Generation Sequencing
    Table 5-5: Selected Agreements between Next Generation Sequencing Companies and Pharmaceutical or Biopharmaceutical Companies [Includes Contract Research Organizations Providing Services to Pharma Companies]
    Table 5-6: Selected Pharmaceutical and Biopharmaceutical Companies Using or Active in Next Generation Sequencing
    Table 5-7: Selected Company Agreements between Two Next Generation Sequencing Companies [Includes IT Companies in NGS]
    Table 5-8: Selected Other Next-Generation Sequencing Company Agreements in Next Generation Sequencing [Includes IT Companies in NGS]
    Table 5-9: Selected Next Generation Sequencing Company Agreements with Academic or Other Non-Profit Organizations [Includes IT Companies in NGS]
    7: Sequencing Market Analysis
    Table 7-1: Sequencing Market, Worldwide, 2015 and 2020 (Instrument Revenue, Consumables Revenue, Services Revenue, Total Market)
    Table 7-2: Sequencing Market by Geographical Region, Worldwide, 2015 and 2020 (North America, Europe, Asia, Rest of World, Total Market)
    Figure 7-2: Next Generation Sequencing System Ownership by Country, Percentage (United States, China, Germany, UK, South Korea, Spain, Canada, France, Australia, Netherlands, Italy, Taiwan, Brazil, Japan, India, Sweden, Belgium, Denmark, Switzerland, Singapore, Saudi Arabia, Others)
    Figure 7-3: Next Generation Sequencing System Ownership by Brand (HiSeq2000, Genome Analyser, Roche 454, ABI SOLiD, Ion Torrent, MiSeq, Ion Proton, Pacific Biosciences, Oxford Nanopore MinION, Polonator, NextSeq)
    Figure 7-5: Research Sequencing Market – Types of Sequencing: Targeted or Whole Exome Sequencing versus de novo or Whole Genome Sequencing (2015)
    Figure 7-6: Clinical Sequencing Market by Disease Category, 2015, Percentage (Genetic Testing/Inherited Disorders, Other Disorders)
    Figure 7-7: Clinical Sequencing Market by Disease Category, 2020, Percentage(Oncology, Genetic Testing/Inherited Disorders, Infectious Disease, Other Disorders)
    Table 7-3: Investments in Next Generation Sequencing Companies, 2015 and First Half of 2016
    8: Company Profiles - Next Generation Sequencing Companies
    Table 8-1: Abbott Revenues (2013, 2014, 2015)
    Table 8-2: Agilent Technologies Revenues (2013, 2014, 2015)
    Table 8-3: Becton, Dickinson and Company (BD) Revenues (2013, 2014, 2015)
    Table 8-4: bioMérieux Revenues (2013, 2014, 2015)
    Table 8-5: bioMérieux Revenues (2014 and 2015) - By Region, and by Technology and Application
    Table 8-6: Cancer Genetics Revenues (2013, 2014, 2015)
    Table 8-7: CareDx Revenues (2013, 2014, 2015)
    Table 8-8: Foundation Medicine Revenues (2013, 2014, 2015)
    Table 8-9: Genomic Health Revenues (2013, 2014, 2015)
    Table 8-10: HTG Molecular Diagnostics (2014 and 2015)
    Table 8-11: Illumina (2013, 2014, 2015)
    Table 8-12: Invitae Corporation Revenues (2013, 2014, 2015)
    Table 8-13: Laboratory Corporation of America (LabCorp) Revenues (2013,2014, 2015)
    Table 8-14: Myriad Genetics Revenues (2013, 2014, 2015)
    Table 8-15: NeoGenomics Revenues (2013, 2014, 2015)
    Table 8-16: Pacific Biosciences Revenues (2013, 2014, 2015)
    Table 8-17: QIAGEN Revenues (2013, 2014, 2015)
    Table 8-18: QIAGEN – Distribution of Sales in 2015
    Table 8-19: Quest Diagnostics Revenues (2013, 2014, 2015)
    Table 8-20: Roche Revenues (2014 and 2015)
    Table 8-21: Siemens Revenues (2014 and 2015)
    Table 8-22: Sysmex Revenues (2013, 2014, 2015)
    Table 8-23: Thermo Fisher Scientific Revenues (2013, 2014, 2015)
  • Download our eBook: How to Succeed Using Market Research

    Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

    Download eBook

    Share this report